Physician

Raymond Charles Hausch, MD

According to 2025 Medicare claims, Raymond Hausch, MD (NPI: 1639114358) practices rheumatology in the Salem, OR market, with the plurality of this provider's patient population coming from Marion, OR. This provider's primary affiliated billing organization is OREGON ONCOLOGY SPECIALISTS, LLP (NPI: 1013953025; TIN: 93-1273254) and primary practice location at 97301-5057.

Hausch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 168 traditional Medicare patients, billed 16,451 HCPCS/CPT codes, and received $287,029 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 1,820 prescription claims across 268 beneficiaries totaling $1,151,737 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 48 records totaling $1,222. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $44,850 to $287,029. In contrast, Part D prescription costs have fallen sharply in recent years, from $706,056 to $1,151,737. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$144K$287K2015 Medicare payment: $44,850 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $25,545 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $35,685 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $35,212 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $31,442 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $47,338 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $55,739 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $168,824 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $206,877 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $287,029 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015179945$44,850
2016283933$25,545
20172821,125$35,685
2018531994$35,212
20196211,193$31,442
20205463,979$47,338
20215764,525$55,739
202215314,289$168,824
202317715,916$206,877
202416816,451$287,029

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.0M$6.0M2015 Drug cost: $706,056 (USD; Tot_Drug_Cst)2016 Drug cost: $1,569,335 (USD; Tot_Drug_Cst)2017 Drug cost: $2,267,273 (USD; Tot_Drug_Cst)2018 Drug cost: $3,113,938 (USD; Tot_Drug_Cst)2019 Drug cost: $3,732,418 (USD; Tot_Drug_Cst)2020 Drug cost: $4,965,931 (USD; Tot_Drug_Cst)2021 Drug cost: $6,017,957 (USD; Tot_Drug_Cst)2022 Drug cost: $1,742,961 (USD; Tot_Drug_Cst)2023 Drug cost: $750,228 (USD; Tot_Drug_Cst)2024 Drug cost: $1,151,737 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154932,339$706,056
20164653,074$1,569,335
20175424,018$2,267,273
20186713,495$3,113,938
20195363,986$3,732,418
20205574,199$4,965,931
20215594,303$6,017,957
20224321,603$1,742,961
20232201,385$750,228
20242681,820$1,151,737

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
80053Blood test, comprehensive group of blood chemicals67127$10
36415Insertion of needle into vein for collection of blood sample84147$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count66120$8
86140Measurement c-reactive protein for detection of infection or inflammation71122$5
85651Red blood cell sedimentation rate, to detect inflammation, non-automated70126$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab501,400$339,623
Xeljanz XrTofacitinib Citrate31930$187,796
EnbrelEtanercept22616$162,757
Cosentyx Unoready PenSecukinumab12336$111,699
OtezlaApremilast12360$67,911

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.48$1,222Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Raymond Charles Hausch, MD?

Tedicare shows public-source Medicare data for Raymond Charles Hausch, MD (NPI 1639114358), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raymond Charles Hausch, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Raymond Charles Hausch, MD?

Raymond Charles Hausch, MD is linked to OREGON ONCOLOGY SPECIALISTS, LLP (billing NPI 1013953025) in the available physician profile data.

Does Raymond Charles Hausch, MD have Open Payments data?

Raymond Charles Hausch, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.